No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
769 |
4. Check minimum number of eventsNone |
769 |
5. Include endpointsNone |
769 |
6. Filter based on genotype QC (FinnGen only) |
769 |
Control definitions (FinnGen only)
- Control exclude
- G6_HYDROCEPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G91
- Name in latin
- Hydrocephalia communicans
Similar endpoints
↥List of similar endpoints to
Communicating hydrocephalus
based on the number of shared cases.
Similar with more cases:
- Hydrocephalus
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6750 | 3351 | 3305 |
| Only index persons | 4677 | 2460 | 2217 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.09 |
| Only index persons | 0.09 | 0.09 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 59.21 | 61.43 | 56.68 |
| Only index persons | 55.27 | 58.24 | 51.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 769 | 403 | 366 |
| Unadjusted period prevalence (%) | 0.15 | 0.14 | 0.16 |
| Median age at first event (years) | 60.46 | 59.84 | 61.15 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 696
- Matched controls
- 6960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
1904.2
323.0
366
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
323.0
626
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
273.5
244
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
209.2
190
*
AAF00
NOMESCO Finland
Ventriculostomy
502.2
191.9
183
5
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
163.1
150
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
129.0
159.5
167
17
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
149.5
138
*
AA1AD
NOMESCO Finland
CT of head and brain
7.6
127.4
404
1070
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
61.7
116.4
135
27
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
16.6
108.8
183
146
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
101.6
95
*
AA1AA
NOMESCO Finland
Head X-ray examination
116.0
101.3
108
11
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
+∞
98.3
92
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
1003.6
92.0
88
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
977.5
89.8
86
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
77.6
73
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
52.9
70.5
84
18
ZXD05
NOMESCO Finland
Urgent procedure
4.3
67.2
357
1376
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
677.2
63.9
62
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
52.4
62.9
75
16
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
58.1
55
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
56.9
57.1
67
13
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
9.1
54.8
122
159
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
81.7
53.9
60
8
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
23.9
50.9
73
34
2132
FHL
Ventricular operators sunt
274.6
50.8
51
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
109.9
47.5
51
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.6
47.0
131
237
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
35.0
44.9
58
18
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
43.2
41
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
49.8
42.6
51
11
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.1
42.1
124
239
R51.80
ICD-10 Finland
Headache
4.1
37.0
164
487
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
36.9
195
673
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
36.7
187
626
XA800
NOMESCO Finland
Neuropsychological investigation
8.1
36.2
85
118
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
36.1
200
713
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
9.8
36.0
75
85
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
35.2
331
1698
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
58.9
33.6
39
7
N03AX14
ATC
levetiracetam; systemic
10.2
33.1
67
72
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
51.5
32.8
39
8
K90
ICPC
Stroke/cerebrovascular accident
8.9
31.1
68
84
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.6
30.8
58
54
N03AG01
ATC
valproic acid; systemic, rectal
6.0
30.5
89
167
N03AB02
ATC
phenytoin; systemic
18.8
30.0
46
26
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.6
29.9
54
46
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
28.2
29.6
40
15
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.2
29.3
56
54
K91
ICPC
Cerebrovascular disease
18.0
28.3
44
26
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
11.2
28.2
54
52
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.4
28.1
69
102
Z2445
NOMESCO Finland
Psychologist
7.0
25.6
65
101
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
12.5
25.6
46
39
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
25.2
24
*
2133
FHL
Suntin revisio
258.9
24.8
25
*
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
93.5
24.8
27
*
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
24.1
23
*
TAB00
NOMESCO Finland
Lumbar puncture
5.6
23.1
70
137
N18
ICPC
Paralysis/weakness
10.2
22.6
45
47
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
21.6
102
310
N03AF02
ATC
oxcarbazepine; oral
6.8
21.1
54
85
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
15.5
20.9
34
23
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.8
20.8
95
281
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
33.7
20.3
26
8
ZXD35
NOMESCO Finland
Usual procedure
5.9
20.1
57
103
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
59.3
20.0
23
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
59.3
20.0
23
*
N03AF01
ATC
carbamazepine; oral, rectal
4.6
19.8
72
172
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
19.8
263
1490
ZXA00
NOMESCO Finland
Right side
2.3
19.7
234
1256
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
20.1
19.6
29
15
R4150
NOMESCO Finland
Neuropsychological rehabilitation
32.3
19.4
25
8
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
14.5
19.2
32
23
SPAT1216
SPAT
Assessment of functional ability
2.6
19.2
159
705
SPAT1229
SPAT
Assessment of need for aid
3.5
19.1
96
306
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
19.1
86
251
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
18.8
18
*
G91
ICD-10 Finland
Hydrocephalus
+∞
18.8
18
*
H47.2
ICD-10 Finland
Optic atrophy
28.7
18.8
25
9
2161
FHL
Neck ligation, big brain
28.7
18.8
25
9
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.7
18.6
65
149
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
18.2
84
250
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.9
18.0
45
69
R42
ICD-10 Finland
Dizziness and giddiness
2.3
18.0
194
989
A28
ICPC
Limited function/disability NOS
2.5
17.8
155
706
N28
ICPC
Limited function/disability (N)
9.6
17.3
35
38
L28
ICPC
Limited function/disability (L)
2.5
17.2
155
717
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.4
17.2
88
285
A06AD11
ATC
lactulose; oral
2.5
16.7
150
690
-
ICD-10 Finland
NA
7.3
16.6
40
58
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.4
16.6
44
73
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
174.0
16.6
17
*
H53.4
ICD-10 Finland
Visual field defects
8.1
16.5
37
48
183
Kela drug reimbursment
Lamotrigin and topiramate
14.7
16.4
27
19
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
41.1
16.4
20
5
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.2
16.2
51
105
XCK00
NOMESCO Finland
Perimetry
3.4
16.0
81
260
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
61.5
15.8
18
*
2130
FHL
Ventricular atrial shunt
+∞
15.7
15
*
2124
FHL
Intracranial pressure measurement, intraventricular
+∞
15.7
15
*
N06AB04
ATC
citalopram; systemic
2.2
15.5
177
917
G44.2
ICD-10 Finland
Tension-type headache
2.9
15.5
101
386
R53
ICD-10 Finland
Malaise and fatigue
2.3
15.5
173
889
N05BA09
ATC
clobazam; oral
20.6
15.2
22
11
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
15.1
96
361
R1250
NOMESCO Finland
Evaluation of functional capability
7.9
15.1
34
45
N29
ICPC
Neurological sympt/complt other
7.5
14.9
35
49
N05AH04
ATC
quetiapine; oral
2.5
14.8
124
547
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.2
14.7
26
22
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
14.7
285
1831
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.1
14.6
84
295
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
10.4
14.6
28
28
P20
ICPC
Memory disturbance
2.5
14.3
119
525
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
14.3
73
236
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.9
14.1
93
357
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
7.3
14.0
33
47
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
18.0
13.9
21
12
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
13.9
209
1211
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
20.5
13.8
20
10
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.9
13.8
31
41
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
34.8
13.6
17
5
M03BX01
ATC
baclofen; systemic
9.3
13.3
27
30
R4120
NOMESCO Finland
Occupational therapy
3.4
13.3
65
203
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
12.8
118
547
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
12.7
135
671
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.8
12.7
84
321
S06.0
ICD-10 Finland
Concussion
2.6
12.6
95
395
N99
ICPC
Neurological disease other
11.3
12.6
23
21
2139
FHL
Other measure in this category
+∞
12.5
12
*
G81.1
ICD-10 Finland
Spastic hemiplegia
+∞
12.5
12
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
132.3
12.5
13
*
N03AX09
ATC
lamotrigine; oral
4.5
12.3
43
100
F03
ICD-10 Finland
Unspecified dementia
3.3
11.8
60
194
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
30.6
11.7
15
5
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
11.7
115
551
T90.5
ICD-10 Finland
Sequelae of intracranial injury
10.3
11.6
22
22
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
11.6
67
237
I60.5
ICD-10 Finland
Subarachnoid haemorrhage from vertebral artery
+∞
11.5
11
*
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
11.5
11
*
AAK00
NOMESCO Finland
Cranioplasty
121.9
11.5
12
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.3
11.3
41
99
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
13.0
11.2
19
15
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.4
11.1
22
24
G41.9
ICD-10 Finland
Status epilepticus, unspecified
14.2
11.0
18
13
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
14.2
11.0
18
13
G04BD07
ATC
tolterodine; oral
3.0
11.0
63
221
R51
ICD-10 Finland
Headache
3.9
11.0
45
122
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
44.0
10.9
13
*
G03.9
ICD-10 Finland
Meningitis, unspecified
44.0
10.9
13
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
44.0
10.9
13
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
10.9
142
766
N02BE01
ATC
paracetamol; systemic, rectal
1.9
10.8
572
4907
SPAT1234
SPAT
Support of social functional capacity
3.2
10.8
56
184
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
10.7
129
675
N05AX08
ATC
risperidone; systemic
2.7
10.6
74
294
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.0
10.6
33
68
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
+∞
10.4
10
*
AAK80
NOMESCO Finland
Partial excision of skull cap
+∞
10.4
10
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
10.3
80
336
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
23.8
10.3
14
6
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
10.2
58
203
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.5
10.1
18
16
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
10.0
82
357
ZXC86
NOMESCO Finland
Use of endoscopic device
17.0
9.9
15
9
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.4
9.7
46
142
N05BA01
ATC
diazepam; systemic, rectal
2.2
9.6
107
538
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.9
9.6
38
101
2127
FHL
Ventriculostomy
101.4
9.4
10
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
30.5
9.4
12
*
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
9.4
9
*
Z3231
NOMESCO Finland
Registered nurse
1.8
9.4
192
1215
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
9.3
97
473
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.6
9.3
26
48
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.0
9.1
24
41
N03AX18
ATC
lacosamide; systemic
11.7
9.1
16
14
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
37.2
9.0
11
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.6
9.0
40
117
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.9
9.0
24
42
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
24.4
8.9
12
5
AA5PD
NOMESCO Finland
CT examination of brain pefusion
10.9
8.8
16
15
H47.1
ICD-10 Finland
Papilloedema, unspecified
16.5
8.6
13
8
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.5
8.5
21
33
WX704
NOMESCO Finland
Intubation
2.8
8.5
55
210
2152
FHL
Extraction, big brain
91.1
8.4
9
*
N06AB10
ATC
escitalopram; oral
2.0
8.4
122
682
Z75.5
ICD-10 Finland
Holiday relief care
8.0
8.4
18
23
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
+∞
8.3
8
*
T85.7
ICD-10 Finland
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
+∞
8.3
8
*
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
+∞
8.3
8
*
34793
ICD-8 Finland
Other disease of brain, Hydrocephalus acquisitus NUD
+∞
8.3
8
*
Q03.0
ICD-10 Finland
Malformations of aqueduct of Sylvius
+∞
8.3
8
*
Z03
ICPC
Housing/neighbourhood problem
10.9
8.3
15
14
WYA20
NOMESCO Finland
Home visit
5.5
8.2
23
43
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
11.9
8.1
14
12
AA9CW
NOMESCO Finland
NA
33.8
8.1
10
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
10.2
8.1
15
15
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
10.2
8.1
15
15
RT150
NOMESCO Finland
NA
22.3
8.0
11
5
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
8.0
79
377
N05CD08
ATC
midazolam; nasal, systemic
4.3
8.0
28
67
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.2
7.9
13
10
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
11.0
7.8
14
13
U04
ICPC
Incontinence urine
2.8
7.8
49
184
SPAT1053
SPAT
Memory test
1.9
7.7
122
705
R11
ICD-10 Finland
Nausea and vomiting
2.3
7.6
70
323
G40.10
ICD-10 Finland
Simple partial seizures
8.2
7.6
16
20
RS313
NOMESCO Finland
NA
25.3
7.6
10
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.3
7.6
19
31
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
7.6
112
631
N05AH03
ATC
olanzapine; systemic
3.2
7.5
38
124
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.2
7.5
17
24
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.2
7.5
38
125
R5599
NOMESCO Finland
Other rehabilitation service
4.0
7.4
28
72
I60
ICD-10 Finland
Subarachnoid haemorrhage
80.9
7.4
8
*
R55
ICD-10 Finland
Syncope and collapse
2.1
7.4
86
439
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.4
7.4
25
58
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.4
183
1219
G40
ICD-10 Finland
Epilepsy
8.5
7.3
15
18
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
9.5
7.3
14
15
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
9.5
7.3
14
15
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
7.3
7
*
GBB03
NOMESCO Finland
Percutaneous tracheostomy
+∞
7.3
7
*
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
7.3
7
*
OAB43
SPAT
NA
0.2
7.3
9
378
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.4
7.2
16
22
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.4
7.1
20
38
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
2.6
7.1
49
194
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.9
7.1
14
16
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.5
7.0
31
92
GBB00
NOMESCO Finland
Tracheostomy
5.9
6.9
18
31
N05AD01
ATC
haloperidol; systemic
3.5
6.9
30
88
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.1
6.8
20
40
SPAT1252
SPAT
Overall medication plan or its review
2.3
6.8
60
273
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
40.4
6.8
8
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
40.4
6.8
8
*
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
40.4
6.8
8
*
RL140
NOMESCO Finland
NA
16.9
6.8
10
6
XX4AW
NOMESCO Finland
NA
16.9
6.8
10
6
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.4
6.7
31
95
SPAT1301
SPAT
No procedures
1.6
6.7
219
1561
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
22.8
6.7
9
*
4309X
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]
22.8
6.7
9
*
N05BA04
ATC
oxazepam; oral
1.7
6.6
162
1071
G40.89
ICD-10 Finland
Other epilepsy
12.4
6.6
11
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
6.6
80
417
F06.7
ICD-10 Finland
Mild cognitive disorder
3.6
6.6
28
81
A04
ICPC
Weakness/tiredness general
1.9
6.4
96
541
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
70.5
6.4
7
*
G90.1
ICD-10 Finland
Familial dysautonomia [Riley-Day]
70.5
6.4
7
*
RT490
NOMESCO Finland
NA
70.5
6.4
7
*
L01AX03
ATC
temozolomide; systemic
14.5
6.4
10
7
G41.0
ICD-10 Finland
Grand mal status epilepticus
14.5
6.4
10
7
D33.30
ICD-10 Finland
Acoustic neuroma
14.5
6.4
10
7
WX882
NOMESCO Finland
High dependency care
3.3
6.4
30
94
ZXA05
NOMESCO Finland
Left side
1.6
6.4
179
1225
N05AD03
ATC
melperone; systemic
5.3
6.4
18
35
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
5.6
6.3
17
31
WW200
SPAT
NA
2.2
6.3
61
289
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.6
6.3
44
176
N30.0
ICD-10 Finland
Acute cystitis
1.9
6.3
100
578
RS122
NOMESCO Finland
NA
+∞
6.3
6
*
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
+∞
6.3
6
*
Q05.2
ICD-10 Finland
Lumbar spina bifida with hydrocephalus
+∞
6.3
6
*
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
6.3
6
*
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
+∞
6.3
6
*
74209
ICD-8 Finland
Congenital hydrocephalus, Unspecified
+∞
6.3
6
*
RP120
NOMESCO Finland
NA
+∞
6.3
6
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
26.9
6.2
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.7
6.2
130
821
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
6.1
134
859
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.3
6.1
13
410
Z08
ICPC
Social welfare problem
6.8
6.1
14
21
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
6.0
58
1030
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
6.0
62
304
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
139
49
34.41
212.28
4.7
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
177
121
18.70
205.60
3.9
1.7
e6/l
37.0
7.0
1.95
146
90
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
177
121
18.70
205.60
3.9
1.8
e6/l
2401.5
1077.2
0.50
146
93
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
91
22
46.78
153.21
4.6
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
138
103
16.11
151.46
4.3
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
103
50
23.63
138.76
4.3
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
96
58
18.77
116.89
4.1
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
107
125
9.78
86.34
3.0
1.6
mmol/l
3.6
3.8
1.11
102
117
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
45
37
12.86
45.66
2.3
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
175
738
2.78
28.16
9.0
8.1
mmol/l
1.6
1.3
0.79
135
591
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
32
35
9.50
26.66
1.2
1.0
ng/l
293.9
280.3
0.05
11
22
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
32
35
9.50
26.66
1.2
1.0
ng/l
34.8
39.9
0.16
11
20
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
32
35
9.50
26.66
1.2
1.0
ng/l
484.1
552.0
—
10
22
(3043409) Potassium [Moles/volume] in Arterial blood
75
208
3.89
23.96
9.6
3.7
mmol/l
3.8
3.9
2.34
75
190
(3011397) Hemoglobin [Presence] in Urine by Test strip
255
1384
2.26
23.24
4.7
4.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
28
9
32.21
21.61
3.0
1.0
%
33.9
—
—
22
0
(40761535) Cells panel - Urine sediment
128
527
2.71
21.16
3.6
3.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
78
246
3.42
20.54
9.1
3.8
mmol/l
1.6
1.3
0.70
78
240
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
308
1872
2.08
20.48
2.9
2.1
u/l
214.8
289.0
0.59
287
1768
(3020891) Body temperature
77
252
3.28
19.10
10.0
4.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
109
440
2.72
18.63
9.3
5.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
105
422
2.72
18.08
15.4
8.0
mmol/l
24.7
24.3
0.29
99
404
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
157
771
2.30
17.59
9.4
7.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
83
1887
0.37
16.92
2.2
3.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
252
1528
1.97
16.06
4.9
4.1
%
90.2
88.4
0.60
242
1489
(3026008) Bacteria identified in Urine by Culture
304
1976
1.89
15.63
4.7
3.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
157
807
2.19
15.61
8.2
7.0
mmol/l
105.1
104.1
1.70
157
787
(3018677) aPTT in Platelet poor plasma by Coagulation assay
179
985
2.07
14.83
2.5
2.2
s
28.8
29.7
0.95
171
950
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
21
29
7.42
14.46
2.4
2.4
umol/l
60.7
49.0
0.61
15
23
(3019150) Specific gravity of Urine by Refractometry
219
1347
1.88
12.91
5.6
4.3
kg/l
1.0
1.0
0.38
16
199
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
27
7.19
12.75
2.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
114
560
2.22
12.52
2.8
2.5
ug/l
5.4
6.5
0.23
100
490
(3029937) Albumin [Presence] in Urine by Test strip
249
1621
1.79
12.08
5.6
4.2
estimate
0.0
0.0
0.50
45
532
(3023368) Bacteria identified in Blood by Culture
265
1776
1.75
11.53
4.8
4.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
231
1489
1.79
11.49
2.6
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
280
1962
1.67
10.05
2.8
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
312
2264
1.64
9.68
4.1
3.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
144
855
1.84
9.18
5.8
5.9
mmol/l
1.0
1.1
1.87
136
790
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
35
5.24
8.92
1.8
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
454
5337
0.64
8.33
24.8
16.8
%
39.6
39.2
0.40
296
3652
(3013512) EKG study
114
1854
0.55
8.09
3.6
4.1
—
—
—
0
0
(4034850)
46
184
2.60
7.97
8.4
9.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
496
5682
0.64
7.55
3.8
4.5
mmol/l
1.4
1.5
2.05
457
5160
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
367
2891
1.52
7.33
8.6
6.4
mmol/l
1.2
1.2
2.65
346
2616
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
476
5490
0.65
7.33
3.8
4.1
mmol/l
1.4
1.3
2.51
443
4959
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
502
5723
0.65
7.27
4.3
4.7
mmol/l
6.0
6.0
0.01
473
5141
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
503
5725
0.65
7.13
4.0
4.5
mmol/l
4.5
4.6
0.91
465
5241
(3000991) Gas panel - Venous blood
97
550
1.87
7.09
7.0
8.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
518
5855
0.65
7.03
4.6
5.1
mmol/l
2.6
2.7
0.72
481
5320
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
481
5505
0.66
6.73
17.7
14.3
ml/min/173m2
83.3
78.0
4.87
405
4524
(3012095) Magnesium [Moles/volume] in Serum or Plasma
152
1021
1.61
6.04
3.6
3.7
mmol/l
0.8
0.8
2.25
142
958
(3013826) Glucose [Moles/volume] in Serum or Plasma
432
3613
1.45
5.86
8.8
5.2
mmol/l
6.9
6.7
0.90
420
3391
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
121
780
1.65
5.65
1.7
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
675
0.41
5.64
1.1
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
130
2.52
5.43
1.9
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
266
0.22
5.31
1.7
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
118
772
1.62
5.19
1.7
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
32
4.12
4.91
2.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
398
0.29
4.89
1.8
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
380
3169
1.39
4.88
9.0
7.1
mmol/l
1.2
1.2
2.16
345
2689
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
488
5459
0.71
4.80
5.4
6.1
mmol/mol
39.6
40.2
0.94
456
5019
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
20
5.05
4.78
1.7
2.5
%
137.5
134.8
—
10
20
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
393
1.80
4.70
1.7
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
90
565
1.67
4.65
6.2
7.5
mmol/l
1.4
1.3
0.13
85
541
(3007853) Bacteria identified in Skin by Aerobe culture
112
745
1.59
4.59
2.3
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
44
814
0.51
4.57
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
771
0.51
4.48
4.5
4.6
%
31.0
32.2
0.32
26
504
(3041096) Erythrocytes [Presence] in Urine by Automated
112
1610
0.64
4.45
5.0
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
132
919
1.53
4.43
2.4
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
151
1082
1.49
4.42
1.7
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
123
844
1.54
4.41
22.7
25.0
inr
1.3
1.3
—
6
114
(3002385) Erythrocyte distribution width [Ratio]
432
4899
0.73
4.36
26.6
19.1
%
13.9
13.8
1.00
424
4788
(40768804) Tissue Pathology biopsy report
179
2318
0.70
4.09
2.2
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
38
190
2.05
4.05
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
350
2943
1.35
4.00
5.1
4.0
estimate
0.0
0.0
0.00
48
553
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
320
3757
0.75
3.83
3.2
3.1
u/l
50.8
50.8
0.00
297
3473
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
335
2818
1.33
3.74
4.5
4.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
197
0.25
3.57
5.4
5.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
9
7.84
3.56
1.3
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
24
500
0.46
3.55
6.8
3.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
589
6304
0.72
3.52
11.0
10.7
u/l
25.6
25.4
0.07
571
6053
(3024561) Albumin [Mass/volume] in Serum or Plasma
322
2715
1.32
3.46
5.3
5.0
g/l
34.3
35.3
2.38
298
2529
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
39
685
0.55
3.43
3.2
4.1
ug/l
4.3
26.6
1.25
34
581
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
210
1.90
3.41
5.8
2.9
u/ml
0.3
0.4
0.11
24
118
(3021601) Nitrite [Presence] in Urine by Test strip
346
2954
1.31
3.38
6.0
5.4
estimate
0.0
0.0
0.00
49
546
(21494755) Public health laboratory ask at order entry panel
18
410
0.43
3.37
1.3
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
159
1211
1.39
3.31
2.9
3.1
mmol/l
2.5
2.5
0.15
141
1066
(3009261) Glucose [Presence] in Urine by Test strip
349
2991
1.31
3.29
5.0
4.0
estimate
0.0
0.0
0.50
48
531
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
54
2.81
3.27
2.3
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
145
1098
1.40
3.12
3.4
2.9
e6/l
1.9
1.1
0.94
87
639
(3000492) Spirometry study
27
514
0.51
3.09
1.2
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
46
750
0.59
3.09
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
171
1335
1.36
3.05
3.1
2.7
e6/l
5.9
5.6
0.10
157
1174
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
923
0.63
3.01
1.1
1.3
u/ml
14.5
10.1
0.25
20
337
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
575
0.55
2.84
1.5
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
116
1526
0.72
2.76
1.2
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
214
1750
1.31
2.76
4.1
3.3
e6/l
0.3
0.5
1.45
176
1328
(3020682) Albumin/Creatinine [Ratio] in Urine
152
1916
0.74
2.75
3.9
4.0
mg/mmol
8.4
8.8
0.05
104
1218
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
466
0.52
2.71
2.6
2.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
214
0.37
2.70
1.4
1.6
—
126.7
—
0
9
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
10
6.04
2.70
1.3
1.0
%
109.5
108.0
—
6
10
(36304419) Bacteria [Presence] in Urine
206
1682
1.31
2.68
4.1
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
272
2305
1.28
2.65
5.5
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
286
2441
1.27
2.63
3.7
3.9
ng/l
27.6
54.6
1.23
215
1798
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
297
3413
0.79
2.61
2.6
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
422
0.51
2.61
2.4
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
188
1523
1.31
2.58
6.5
6.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
68
972
0.67
2.57
1.2
1.3
iu/ml
38.7
36.0
0.07
23
305
(3045414) Leukocytes [Presence] in Urine
40
242
1.69
2.46
2.0
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
124
1.97
2.43
2.2
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
132
1.92
2.38
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
457
0.55
2.34
1.4
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
250
2125
1.26
2.33
3.1
3.5
mmol/l
2.4
2.4
0.34
219
1852
(3003338) MCHC [Mass/volume]
534
4942
1.26
2.32
28.4
20.3
g/l
332.2
332.1
0.04
526
4893
(3008898) HLA-B27 [Presence]
8
201
0.39
2.32
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
202
0.39
2.32
1.1
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
334
1.56
2.31
9.4
11.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
88
645
1.41
2.30
3.7
4.5
mmol/l
1.4
1.9
0.57
70
513
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
1164
0.72
2.28
2.4
3.1
ug/l
0.6
0.8
1.16
63
769
(3000963) Hemoglobin [Mass/volume] in Blood
630
6591
0.76
2.26
30.9
22.7
g/l
131.9
134.3
3.63
616
6466
(3018418) pH of Serum or Plasma
221
1857
1.27
2.26
4.1
4.0
ph
7.4
7.4
0.26
18
338
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
18
3.91
2.25
1.1
1.0
miu/ml
1701.9
1751.1
—
7
18
(3010813) Leukocytes [#/volume] in Blood
630
6589
0.76
2.23
30.8
22.5
e9/l
7.2
6.8
4.33
614
6373
(3026361) Erythrocytes [#/volume] in Blood
630
6588
0.76
2.22
30.8
22.5
e12/l
4.4
4.5
3.20
614
6369
(3035941) MCH [Entitic mass]
630
6587
0.76
2.20
30.6
22.4
pg
30.2
30.3
0.40
618
6464
(3024731) MCV [Entitic volume]
630
6586
0.76
2.19
30.7
22.4
fl
90.9
91.1
0.39
617
6464
(3007461) Platelets [#/volume] in Blood
630
6585
0.76
2.18
30.7
22.5
e9/l
256.7
245.9
3.28
614
6389
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
68
483
1.45
2.12
3.5
2.8
ml/min/173m2
71.5
64.3
0.53
26
200
(3052851) Hemolysis interference index of Serum or Plasma
30
176
1.73
2.09
5.2
3.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
54
772
0.68
2.06
1.2
1.3
titre
1040.0
455.0
0.79
14
168
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
42
274
1.56
1.96
2.7
2.0
ug/l
3.8
2.6
0.18
37
244
(3026389) Candida sp identified in Specimen by Organism specific culture
16
78
2.07
1.92
1.1
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
48
691
0.67
1.91
1.5
2.3
ug/g
292.6
139.9
0.44
39
539
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
128
1025
1.30
1.91
4.5
3.2
e6/l
2.5
2.1
0.22
72
570
(4094501)
5
139
0.36
1.90
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
153
1255
1.27
1.89
1.6
1.8
nmol/l
1384.2
1186.4
2.05
127
934
(46235355) HIV 1 and 2 tests - Meaningful Use set
58
803
0.70
1.87
2.1
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
86
2.00
1.86
2.2
2.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
46
2.41
1.86
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
150
1807
0.79
1.86
3.5
3.2
mg/l
833.1
298.1
0.46
105
1160
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
62
445
1.43
1.85
2.3
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
12
4.19
1.82
1.4
1.9
umol/l
16.2
16.5
—
5
12
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
286
0.52
1.81
1.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
167
0.41
1.80
1.1
1.2
—
656.0
—
0
5
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
18
3.35
1.75
2.3
1.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
47
0.00
1.71
0.0
2.3
—
555.3
—
0
29
(3002582) Erythrocytes [#/volume] in Urine
221
1910
1.22
1.71
4.6
3.5
e6/l
48.0
93.5
0.64
184
1479
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
385
1.43
1.69
1.7
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
163
1926
0.80
1.69
3.3
3.2
mmol/l
7.3
7.4
0.06
144
1599
(3018095) Leukocytes [#/volume] in Urine
250
2194
1.21
1.65
5.7
4.0
e6/l
87.0
84.6
0.03
201
1580
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
129
1558
0.79
1.62
1.6
1.7
mmol/l
1.5
1.4
1.16
113
1284
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
56
2.16
1.61
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
151
1261
1.25
1.61
4.0
3.0
mosm/kgh2o
554.5
552.9
0.03
137
1074
(3019225) pH of Specimen
44
616
0.70
1.54
3.7
4.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
44
0.00
1.51
0.0
2.4
—
41.5
—
0
12
(3032080) INR in Blood by Coagulation assay
292
2617
1.19
1.50
6.6
10.4
inr
1.2
1.3
0.92
62
728
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
128
0.39
1.50
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
669
0.71
1.49
1.5
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
203
0.49
1.49
1.4
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
45
2.24
1.47
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
238
2676
0.84
1.45
8.8
9.9
e9/l
0.0
0.0
0.15
185
2174
(3007566) Smooth muscle Ab [Titer] in Serum
7
154
0.45
1.44
1.1
1.2
—
68.2
—
0
11
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
16
3.14
1.44
1.0
2.1
pmol/l
11.6
15.7
—
5
10
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
155
0.45
1.43
1.7
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
139
0.43
1.40
1.3
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
29
2.43
1.39
10.3
13.2
nmol/l
1725.6
1578.9
—
7
29
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
358
0.63
1.37
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
71
904
0.76
1.37
1.4
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
41
2.21
1.37
2.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
175
2013
0.83
1.36
4.1
5.2
ug/l
3.0
2.8
0.06
158
1780
(3026493) Urate [Moles/volume] in Serum or Plasma
132
1560
0.81
1.36
2.6
2.8
umol/l
343.4
7654.9
6.74
108
1333
(3021440) Promyelocytes/100 leukocytes in Blood
34
486
0.69
1.35
5.0
4.3
%
0.2
0.1
—
10
142
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
28
184
1.54
1.33
3.4
3.3
%
92.1
89.9
0.17
28
173
(4024509)
11
54
2.05
1.33
2.2
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
417
4461
0.86
1.33
3.7
4.2
mm/h
14.9
13.1
1.23
392
4076
(3016038) Potassium [Moles/volume] in Urine
11
55
2.01
1.28
1.3
1.3
mmol/l
35.7
32.1
0.32
11
50
(3045716) Anion gap in Serum or Plasma
8
35
2.30
1.27
1.4
1.5
mmol/l
9.9
9.3
—
8
30
(3018010) Neutrophils/100 leukocytes in Blood
261
2886
0.86
1.26
5.8
5.8
%
57.7
57.3
0.20
246
2697
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
18
290
0.61
1.26
5.0
3.0
u/ml
45.1
68.0
0.46
18
277
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
516
5419
0.85
1.25
4.5
4.6
mu/l
2.0
2.2
0.42
481
4863
(3001122) Ferritin [Mass/volume] in Serum or Plasma
226
2524
0.85
1.24
2.7
2.8
ug/l
110.9
139.6
2.00
212
2288
(44790048)
15
85
1.78
1.23
1.2
1.7
—
—
—
0
0
(44806118)
15
85
1.78
1.23
1.2
1.7
—
—
—
0
0
(44790047)
15
85
1.78
1.23
1.2
1.7
—
—
—
0
0
(44790049)
15
85
1.78
1.23
1.2
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
63
1.92
1.23
2.5
3.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
592
6145
0.84
1.22
20.4
14.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
26
2.32
1.19
8.7
14.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
43
317
1.38
1.17
3.2
3.9
%
54.2
48.6
0.61
43
312
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.4
—
1.0
—
0
34
(3002030) Lymphocytes/100 leukocytes in Blood
266
2921
0.86
1.16
6.1
6.1
%
27.4
27.5
0.05
252
2712
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
39
2.06
1.15
1.5
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
0
35
0.00
1.15
0.0
2.5
—
485.1
—
0
23
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
2.0
2.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
33
458
0.71
1.14
5.2
4.3
%
0.9
0.8
0.03
11
121
(3022096) Basophils/100 leukocytes in Blood
251
2765
0.86
1.13
6.1
6.0
%
0.6
0.7
0.33
239
2572
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
177
2002
0.85
1.13
2.5
3.1
ng/l
1440.4
1603.4
0.15
157
1721
(3006504) Eosinophils/100 leukocytes in Blood
259
2844
0.87
1.12
6.1
5.9
%
2.7
2.9
0.75
246
2643
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
10
51
1.97
1.11
1.8
1.4
u/l
30.4
29.0
—
10
41
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
31
2.27
1.10
1.4
2.8
%
114.9
100.3
—
7
31
(3017181) Myelocytes/100 leukocytes in Blood
39
520
0.74
1.07
4.6
4.1
%
1.0
1.0
0.05
14
160
(40768443) Skin Pathology biopsy report
17
265
0.63
1.06
1.1
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
262
2859
0.87
1.02
6.3
6.2
%
8.9
8.7
0.26
248
2673
(40760892) CBC W Ordered Manual Differential panel - Blood
111
1293
0.83
1.00
5.2
4.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
212
0.61
0.99
3.5
2.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
29
0.00
0.98
0.0
1.6
—
71.5
—
0
23
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
50
1.81
0.97
1.2
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
144
0.55
0.94
1.8
2.3
g/l
131.3
128.3
—
8
107
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
42
325
1.31
0.88
2.9
3.3
%
0.8
0.7
1.81
42
315
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
64
1.73
0.86
1.2
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
343
0.72
0.85
1.1
1.2
iu/ml
179.4
138.8
0.19
13
129
(3035637) Corticotropin [Mass/volume] in Plasma
13
80
1.64
0.85
1.7
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
100
1157
0.84
0.84
1.3
1.5
g/l
2.4
2.4
0.08
53
697
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
45
1.79
0.84
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
181
1.39
0.81
3.7
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
176
0.62
0.80
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
139
1.45
0.80
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
139
1.45
0.80
1.3
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
3.6
—
215.5
—
0
25
(3015183) Erythrocyte sedimentation rate
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
37
472
0.77
0.79
4.4
4.0
%
1.3
0.5
—
6
113
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
175
0.62
0.79
3.7
1.9
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
48
1.67
0.79
1.4
1.2
nmol/l
1.1
1.5
—
8
42
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
149
1331
1.15
0.78
1.4
1.7
pmol/l
466.4
5249056.8
0.50
127
1086
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
97
0.51
0.78
1.2
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
235
1.33
0.77
1.4
2.8
g/l
9.9
10.6
0.45
21
201
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
115
1296
0.87
0.71
1.2
1.3
u/ml
0.7
1.8
2.57
33
338
(3009445) Proteinase 3 Ab [Units/volume] in Serum
19
263
0.72
0.71
1.0
1.6
—
11.8
—
0
8
(3028626) Oxygen [Partial pressure] in Capillary blood
29
221
1.32
0.70
10.8
3.8
kpa
8.7
8.5
0.26
29
204
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
145
0.62
0.70
1.2
1.4
—
—
—
0
0
(4010399)
34
429
0.78
0.68
1.5
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
4.4
5.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
92
0.54
0.67
1.4
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
43
1.63
0.67
2.1
3.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
95
0.52
0.66
4.4
3.8
—
748.5
—
0
10
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
62
1.62
0.65
1.1
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
251
1.29
0.65
1.6
2.7
g/l
3.7
3.7
0.06
19
183
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
127
0.63
0.64
1.5
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
28
216
1.31
0.64
2.4
3.1
g/l
0.4
1.4
1.53
22
189
(3021960) Folate [Moles/volume] in Serum or Plasma
167
1525
1.12
0.64
1.5
1.6
nmol/l
20.6
20.6
0.00
154
1274
(3005719) IgG [Mass/volume] in Serum or Plasma
39
479
0.80
0.64
2.3
2.9
g/l
10.6
10.4
0.09
34
440
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
252
1.28
0.63
1.6
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
252
1.28
0.63
1.6
2.7
g/l
7.2
7.4
0.18
19
190
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
235
1.29
0.62
1.6
2.8
g/l
3.0
3.1
0.30
19
186
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
104
0.57
0.62
6.0
2.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
105
0.57
0.62
3.0
3.4
e9/l
4.9
4.5
—
6
105
(3006653) Thiamine [Moles/volume] in Blood
5
30
1.67
0.61
1.0
1.3
nmol/l
123.0
141.6
—
5
30
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
648
0.84
0.60
4.3
3.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
1.6
—
0
13
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
20
0.00
0.60
0.0
1.6
—
7.9
—
0
11
(3017732) Neutrophils [#/volume] in Blood
32
399
0.79
0.60
3.5
2.9
e9/l
3.8
4.0
0.29
23
311
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
134
1213
1.13
0.60
3.9
4.0
ng/l
312.2
295.6
0.03
109
989
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
64
549
1.18
0.59
2.0
3.2
g/l
67.2
66.3
0.45
56
502
(44806420)
0
23
0.00
0.58
0.0
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
37
1.63
0.55
1.2
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
597
0.84
0.53
1.7
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
9
63
1.43
0.52
1.6
1.3
e6/l
568975.6
190422.2
—
9
44
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
369
0.81
0.52
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
135
0.66
0.52
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
325
0.79
0.52
2.8
4.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
26
206
1.27
0.51
1.5
2.8
g/l
38.9
37.7
0.48
19
176
(1002224) Polysomnography panel
15
202
0.74
0.51
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
335
0.80
0.51
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
109
0.64
0.48
1.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
322
0.80
0.48
2.7
2.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
110
0.63
0.48
3.3
3.8
%
56.1
59.3
—
7
110
(3004588) Protein electrophoresis panel - Serum or Plasma
53
457
1.17
0.48
2.1
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
222
0.76
0.48
2.4
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
83
0.60
0.46
3.2
2.1
pg
34.0
33.0
—
5
83
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
565
0.86
0.45
2.2
2.3
u/l
37.0
118.0
0.46
37
470
(3027008) Opiates [Presence] in Urine
12
163
0.73
0.44
1.7
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
129
0.69
0.43
4.0
2.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
151
0.72
0.43
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
94
0.64
0.42
1.7
2.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
38
444
0.85
0.41
1.2
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
26
314
0.82
0.40
1.5
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
103
0.68
0.39
1.4
1.6
—
—
—
0
0
(4027681)
5
35
1.43
0.39
1.4
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
4.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
111
0.72
0.37
1.0
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
37
1.35
0.37
1.4
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
63
701
0.89
0.36
3.2
4.3
u/l
232.2
267.3
0.86
52
665
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
266
2548
1.07
0.36
2.0
2.0
pmol/l
94.0
94.2
0.03
140
1316
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
179
0.78
0.36
1.2
1.4
ug/g
329.6
285.3
—
9
101
(3003327) Ova and parasites identified in Stool by Light microscopy
14
179
0.78
0.36
1.6
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
154
1636
0.93
0.35
2.2
2.2
mg/l
3.0
3.1
0.12
136
1377
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
615
0.89
0.35
1.4
1.7
%
1.6
1.5
0.75
46
530
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
43
1.40
0.35
1.3
1.4
—
322.0
—
0
5
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
14
177
0.79
0.33
5.0
6.2
mg/l
1.6
1.5
0.13
14
160
(3020961) Endomysium IgA Ab [Titer] in Serum
24
285
0.84
0.33
1.0
1.2
—
26.8
—
0
9
(40767503) Oxygen content in Capillary blood by calculation
10
132
0.75
0.32
2.3
2.6
%
16.8
16.1
—
5
72
(3028300) Cannabinoids [Presence] in Urine
13
164
0.79
0.31
1.6
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
98
0.71
0.31
2.9
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
153
0.78
0.31
1.6
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
53
1.32
0.31
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
100
0.70
0.30
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
184
1.20
0.30
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
55
1.28
0.30
2.3
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
185
1938
0.94
0.29
2.4
2.5
u/l
54.4
56.6
0.32
174
1781
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
155
1633
0.94
0.29
4.1
4.4
%
21.6
21.3
0.10
71
781
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
186
1.19
0.28
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
280
1.15
0.28
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
119
0.75
0.27
1.4
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
19
159
1.20
0.27
1.6
1.8
e6/l
32732.1
13679.5
0.44
14
118
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
71
0.70
0.26
2.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
72
0.69
0.26
1.6
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
75
0.66
0.26
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
245
0.85
0.25
1.7
3.8
g/l
0.5
0.4
—
8
100
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
334
3253
1.05
0.24
5.5
6.3
umol/l
10.5
12.3
2.05
315
3075
(42529406) Shigella sp [Presence] in Stool by Culture
22
189
1.17
0.24
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
1.2
1.5
—
—
—
0
0
(4306422)
9
77
1.17
0.24
1.4
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
78
1.29
0.24
1.4
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
50
546
0.91
0.23
2.5
3.3
ng/l
195.8
235.0
0.35
44
502
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
40
1.25
0.22
1.4
2.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
95
0.73
0.22
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
188
0.85
0.21
1.6
2.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
5.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
4.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
12
0.00
0.21
0.0
2.4
—
6188.2
—
0
12
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
198
2049
0.95
0.21
6.0
6.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
13.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.9
—
0
9
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.0
—
1.7
—
0
8
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
18.4
—
0
14
(3000285) Sodium [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
442
1.09
0.20
7.7
4.3
mmol/l
1.8
1.8
0.04
35
330
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
114
0.79
0.20
2.1
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
176
0.85
0.20
1.7
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
50
1.20
0.19
2.0
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
165
0.85
0.19
1.6
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
428
4208
1.04
0.19
5.8
4.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
137
1.17
0.19
3.1
3.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
81
1.24
0.19
1.1
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
142
0.84
0.17
2.2
1.7
nmol/l
35.1
40.7
0.54
12
135
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
157
1.15
0.17
1.4
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
361
3544
1.04
0.17
9.2
9.1
e9/l
4.6
4.2
2.08
316
3089
(3005570) Glucose [Moles/volume] in Urine
5
68
0.73
0.17
1.6
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
70
0.71
0.16
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
162
0.86
0.16
1.6
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
76
0.79
0.15
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
76
0.79
0.15
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
411
1.07
0.14
4.0
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
1323
0.96
0.14
2.2
1.8
mg/l
1.4
1.3
0.13
101
1031
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
591
5957
0.97
0.13
23.0
15.4
mg/l
27.5
24.7
1.16
505
4755
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
170
1.12
0.13
1.4
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
29
267
1.09
0.13
2.3
2.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
110
0.82
0.13
2.2
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
161
1.12
0.13
1.2
1.7
—
—
—
0
0
(4035726)
51
539
0.94
0.12
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
127
0.86
0.12
1.6
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
163
1.11
0.11
1.2
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
146
0.89
0.10
1.1
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
30
280
1.07
0.10
1.3
2.0
g/l
1.5
1.5
0.13
24
248
(3022948) Iron [Moles/volume] in Serum or Plasma
97
1001
0.96
0.10
2.6
2.5
umol/l
12.4
12.6
0.10
91
926
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
156
0.90
0.10
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
306
3018
1.02
0.10
5.6
5.8
e9/l
0.6
0.6
0.35
259
2591
(3020491) Glucose [Moles/volume] in Blood
5
45
1.11
0.10
2.6
1.9
mmol/l
7.6
6.8
—
5
31
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
48
1.04
0.09
1.2
1.2
—
94.4
—
0
5
(3000494) Fungus identified in Specimen by Culture
75
725
1.04
0.09
1.6
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
73
754
0.96
0.08
1.9
2.9
%
1.9
1.8
0.26
65
677
(3032773) Endomysium IgG Ab [Titer] in Serum
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
68
1.03
0.08
1.6
2.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
71
0.84
0.07
1.2
1.2
nmol/l
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
74
0.81
0.07
7.5
3.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
465
4683
0.98
0.07
6.8
7.6
u/l
82.5
80.8
0.32
444
4363
(3037756) Immunofixation for Serum or Plasma
16
147
1.09
0.07
1.2
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
81
0.86
0.07
1.3
1.2
nmol/l
0.5
0.6
—
7
74
(3023520) Reticulocytes [#/volume] in Blood
58
561
1.04
0.07
2.0
2.8
e9/l
75.0
69.0
0.63
43
431
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
226
1.06
0.06
1.8
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
54
522
1.04
0.06
4.1
3.8
ng/l
85.3
83.5
0.06
44
456
(3024928) Oxygen saturation in Venous blood
16
148
1.08
0.06
2.6
5.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
19
203
0.93
0.06
1.4
1.2
u/ml
0.3
1.8
—
5
16
(3004789) Transferrin [Mass/volume] in Serum or Plasma
90
920
0.98
0.06
2.7
2.5
g/l
2.2
2.3
1.85
85
857
(3006315) Basophils [#/volume] in Blood
306
3033
1.01
0.06
5.7
5.8
e9/l
0.0
0.0
0.37
259
2614
(3023103) Potassium [Moles/volume] in Serum or Plasma
618
6201
0.98
0.05
24.7
18.3
mmol/l
4.0
4.0
1.88
607
6022
(3021788) Differential panel - Synovial fluid
12
110
1.09
0.05
1.4
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
312
3096
1.01
0.05
6.0
5.9
e9/l
1.9
1.9
0.00
268
2718
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
864
0.98
0.03
2.9
2.5
%
23.9
22.2
0.43
77
743
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
139
0.93
0.03
1.6
1.6
iu/l
2.0
6.3
—
5
39
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
454
4523
1.01
0.03
3.7
3.8
pmol/l
15.0
14.9
0.21
415
4028
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
193
1915
1.01
0.03
3.2
3.3
u/l
37.9
32.4
0.30
180
1819
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
118
0.93
0.02
1.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
729
0.99
0.01
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
36
352
1.02
0.01
8.9
4.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
174
1.04
0.00
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
423
4237
1.00
0.00
3.9
4.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
313
3136
1.00
0.00
6.2
6.1
e9/l
0.2
0.2
0.14
272
2746
(3044941) Cell count panel - Synovial fluid
10
105
0.95
0.00
1.4
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
164
0.98
0.00
4.1
4.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
98
1.02
0.00
1.5
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
248
1.01
0.00
1.8
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
35
352
0.99
0.00
5.1
3.0
e6/l
0.2
0.3
0.10
35
340
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
101
0.99
0.00
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.2
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
618
6183
1.00
0.00
25.7
18.2
mmol/l
139.4
139.6
1.21
607
6011
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
251
2507
1.00
0.00
2.2
2.3
nmol/l
77.4
77.7
0.07
229
2213
(40768795) Lymph node Pathology biopsy report
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
60
1.00
0.00
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
55
0.91
0.00
3.6
5.9
%
11.5
10.8
—
5
55
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.6
—
0
5
(3022806) Fractional oxyhemoglobin in Capillary blood
8
79
1.01
0.00
1.5
1.9
%
89.3
89.5
—
8
79
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
7.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.1
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
88
0.91
0.00
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
2.5
—
0.8
—
0
6
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
80
1.00
0.00
1.3
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
41.6
—
0
8
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
7.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
72
720
1.00
0.00
2.2
3.0
umol/l
8.2
8.1
0.01
59
625
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
11.4
—
0
7
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
83.8
—
0
8
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
66.9
—
0
8
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
17.4
—
0
9
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
14.9
—
0.5
—
0
8
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
99
0.91
0.00
1.2
1.7
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HCCOMM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCCOMM | 3.207 [2.83, 3.63] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.446 |
During the follow-up period (1.1.1998 — 31.12.2019), 862 out of 2207 females with G6_HCCOMM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCCOMM | 3.268 [2.82, 3.79] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.014 |
During the follow-up period (1.1.1998 — 31.12.2019), 835 out of 2089 males with G6_HCCOMM died.
Mortality risk
Mortality risk for people of age
years, who have G6_HCCOMM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.237% | 0.734% |
| 5 | 1.673% | 3.6% |
| 10 | 4.418% | 9.74% |
| 15 | 9.011% | 17.976% |
| 20 | 15.437% | 29.439% |
Relationships between endpoints
↥Index endpoint: G6_HCCOMM – Communicating hydrocephalus
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data